Key facts
- This page summarizes Brett D. Begemann's Form 4 filing for EASTMAN CHEMICAL CO (EMN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Oct 2022, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
Footnote F2
Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan.
Footnote F3
Includes 1,027 units credited since May 5, 2022 as hypothetical reinvestment of dividend equivalents.
Footnote F4
Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan.